Reverse engineering zonation-specific and age-specific iPSC-derived cerebrovascular models based on transcriptomic profiling of the human brain
Reverse engineering zonation-specific and age-specific iPSC-derived cerebrovascular models based on transcriptomic profiling of the human brain
批准号:
10321473
负责人:
Myriam Heiman
金额:
$83.31万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-09-15 至 2023-08-31
关键词:
3-DimensionalAgeAgingAutomobile DrivingBiochemical ProcessBloodBlood VesselsBlood capillariesBlood flowBrainBrain DiseasesCell LineCell NucleusCellsCerebrovascular DisordersCerebrovascular systemCollaborationsCuesDevelopmentDiseaseDisease ProgressionEngineeringFunctional disorderGene ExpressionGene Expression ProfilingGenetic ScreeningGenomicsGeometryGoalsHealthHumanHuman EngineeringIn VitroIndividualIntrinsic factorLibrariesMaintenanceModelingMolecularNeurodegenerative DisordersNutrientPathologyPerfusionPhasePhenotypePlayProcessResectedRoleSerumSmall Nuclear RNASourceSupporting CellTissue EngineeringTissuesTranslationsWestern Blottingage relatedagedarteriolebasebrain endothelial cellbrain healthcellular transductioncerebrovascularinduced pluripotent stem cellnext generationphysical processprotein expressionresponseshear stressstem cell technologytraffickingtranscription factortranscriptome sequencingtranscriptomicsvenulewasting
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
Cerebrovascular dysfunction is emerging as a common pathology in many diseases of the brain, including
neurodegenerative diseases, cerebrovascular diseases, as well as in aging. Therefore, understanding the role
of cerebrovascular dysfunction in disease progression and aging will be key to long-term maintenance of brain
health. With developments in tissue engineering and stem cell technology, in vitro cerebrovascular models can
play an important role in understanding the role of cerebrovascular dysfunction in disease progression and
aging.
Next-generation cerebrovascular models should take into account three key factors: (1) differences in
phenotype of brain microvascular endothelial cells along the arterio-venous axis, (intrinsic factors), (2)
differences in microenvironmental cues along the arterio-venous axis (extrinsic factors), and (3) changes in
zonation-specific cerebrovascular phenotype during aging and in response to aged serum. Therefore, the
overall goal of this project is to use zonation- and age-specific intrinsic and extrinsic cues to reverse engineer
human cerebrovascular models, and to use these models to understand cerebrovascular phenotype during
aging. We will first perform a pooled genetic screen to identify transcription factor combinations that are
capable of driving source cells towards gene expression profiles of human brain microvascular endothelial cells
along the arterio-venous axis (Aim 1). Three candidate induced brain microvascular endothelial cells (iBMECs)
for each zone will be generated using lentiviral transduction. The top candidate for each zone will then be
selected from analysis of gene and protein expression profiles (Aim 2). We will then use the three iBMECs to
demonstrate zonation-specific cerebrovascular phenotype in zonation-specific models (arteriole, capillary,
venule) (Aim 3). Next, we will assess the influence of young and old serum on cerebrovascular phenotype in
the zonation-specific models (Aim 4). Finally, we will use the same approach to create an aged
cerebrovascular model in one zone. We will create iBMECs that match the transcription factor profile of human
brain microvascular endothelial cells in the aged cerebrovasculature, and then assess the role of
microenvironmental cues and young/old serum on cerebrovascular phenotype.
This project is a collaboration between the Searson group (JHU) with expertise in tissue-engineered
microvascular models, and the Heiman group (MIT) with expertise in genomics and molecular mechanisms of
neurodegenerative disease. This project builds upon key recent accomplishments from the two labs: (1) the
creation of a library of zonation-specific transcription factor profiles for brain microvascular endothelial cells
from the human brain, (2) identification of key transcription factors to enable reverse engineering of zonation-
specific human brain microvascular endothelial cells, and (3) tissue-engineered platforms for zonation-specific
cerebrovascular models.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Molecular Mechanisms Underlying Cell Type-Specific Vulnerability in Huntington’s Disease
-
批准号:10457670
-
项目类别:
-
资助金额:$54.29万
-
财政年份:2022
-
负责人:Myriam Heiman
-
依托单位:
Molecular Mechanisms Underlying Cell Type-Specific Vulnerability in Huntington’s Disease
-
批准号:10614595
-
项目类别:
-
资助金额:$54.29万
-
财政年份:2022
-
负责人:Myriam Heiman
-
依托单位:
Single-cell multi-region transcriptional and epigenomic dissection of VCID.
-
批准号:10532050
-
项目类别:
-
资助金额:$305.85万
-
财政年份:2022
-
负责人:Myriam Heiman
-
依托单位:
Single Cell Transcriptomic and Epigenomic Dissection of Opioid and Cocaine Responses in HIV
-
批准号:10672447
-
项目类别:
-
资助金额:$243.39万
-
财政年份:2021
-
负责人:Myriam Heiman
-
依托单位:
Determinants of cell type-specific vulnerability in Huntington's disease
-
批准号:10440179
-
项目类别:
-
资助金额:$36.5万
-
财政年份:2021
-
负责人:Myriam Heiman
-
依托单位:
Single Cell Transcriptomic and Epigenomic Dissection of Opioid and Cocaine Responses in HIV
-
批准号:10478928
-
项目类别:
-
资助金额:$244.79万
-
财政年份:2021
-
负责人:Myriam Heiman
-
依托单位:
Reverse engineering zonation-specific and age-specific iPSC-derived cerebrovascular models based on transcriptomic profiling of the human brain
-
批准号:10916740
-
项目类别:
-
资助金额:$45.78万
-
财政年份:2021
-
负责人:Myriam Heiman
-
依托单位:
Single Cell Transcriptomic and Epigenomic Dissection of Opioid and Cocaine Responses in HIV
-
批准号:10220620
-
项目类别:
-
资助金额:$246.19万
-
财政年份:2021
-
负责人:Myriam Heiman
-
依托单位:
Determinants of cell type-specific vulnerability in Huntington's disease
-
批准号:9418649
-
项目类别:
-
资助金额:$40.03万
-
财政年份:2017
-
负责人:Myriam Heiman
-
依托单位:
Determinants of cell type-specific vulnerability in Huntington's disease
-
批准号:9285159
-
项目类别:
-
资助金额:$40.03万
-
财政年份:2017
-
负责人:Myriam Heiman
-
依托单位:
Determinants of cell type-specific vulnerability in Huntington's disease
-
批准号:9910469
-
项目类别:
-
资助金额:$40.03万
-
财政年份:2017
-
负责人:Myriam Heiman
-
依托单位:
Development of SLIC, a methodology for synthetic lethal screening in the CNS
-
批准号:8889737
-
项目类别:
-
资助金额:$35.4万
-
财政年份:2013
-
负责人:Myriam Heiman
-
依托单位:
Development of SLIC, a methodology for synthetic lethal screening in the CNS
-
批准号:9097820
-
项目类别:
-
资助金额:$35.4万
-
财政年份:2013
-
负责人:Myriam Heiman
-
依托单位:
Development of SLIC, a methodology for synthetic lethal screening in the CNS
-
批准号:8639854
-
项目类别:
-
资助金额:$34.6万
-
财政年份:2013
-
负责人:Myriam Heiman
-
依托单位:
Development of SLIC, a methodology for synthetic lethal screening in the CNS
-
批准号:8742024
-
项目类别:
-
资助金额:$35.05万
-
财政年份:2013
-
负责人:Myriam Heiman
-
依托单位:
Animal Core
-
批准号:8150139
-
项目类别:
-
资助金额:$41.42万
-
财政年份:2010
-
负责人:Myriam Heiman
-
依托单位:
Cell Specific Analysis of Psychostimulant Drug Action
-
批准号:7254079
-
项目类别:
-
资助金额:$5.2万
-
财政年份:2006
-
负责人:Myriam Heiman
-
依托单位:
Cell Specific Analysis of Psychostimulant Drug Action
-
批准号:7113453
-
项目类别:
-
资助金额:$5.04万
-
财政年份:2006
-
负责人:Myriam Heiman
-
依托单位:
Animal Core
-
批准号:8328721
-
项目类别:
-
资助金额:$45.19万
-
财政年份:--
-
负责人:Myriam Heiman
-
依托单位:
Animal Core
-
批准号:8382719
-
项目类别:
-
资助金额:$32.9万
-
财政年份:--
-
负责人:Myriam Heiman
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: